A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are ...

Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

A new study suggests that GLP-1 agonist medications like Ozempic, which are used for diabetes management and weight loss, may ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical ...

GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 weight ...